Saudi FDA denies approving camel urine extract for cancer treatment
The Saudi Food and Drug Authority has refuted claims it approved a camel urine extract product for cancer treatment, clarifying it is only a dietary supplement.
Key Takeaways
AIThe Saudi Food and Drug Authority has denied rumors that it approved a drug derived from the active ingredient in camel urine for the treatment of cancer.
In a statement on X, the authority addressed claims circulating about the approval of a camel urine extract product for cancer treatment and assertions regarding its effectiveness in curing advanced cases of the disease.
The authority clarified that the product in question is registered as a dietary supplement and contains a blend of vitamins and minerals intended to meet daily nutritional needs. Its use is limited to this purpose, with no therapeutic claims or approval for use in cancer treatment.
View the post on X